![](https://endpts.com/wp-content/uploads/2020/10/David-Ricks-Lilly-tile-AP-scaled.jpg)
David Ricks, Eli Lilly CEO (Evan Vucci/AP Images)
Eli Lilly unveils a complete makeover, erecting a neuroscience unit centered on Alzheimer's as it unifies oncology biz
The FDA approval of Biogen’s Aduhelm for Alzheimer’s has breathed new life into neurology units across biopharma, none more so than nearest rival Eli Lilly …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.